标题
The use of biologics in pregnant patients with rheumatic disease
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 10, Issue 6, Pages 661-669
出版商
Informa UK Limited
发表日期
2017-03-23
DOI
10.1080/17512433.2017.1305268
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy
- (2016) Wai-Kay Seto et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy
- (2016) Gabriella Bröms et al. Clinical Gastroenterology and Hepatology
- The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response
- (2016) Sarah Sheibani et al. DIGESTIVE DISEASES AND SCIENCES
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients
- (2016) Frauke Förger et al. JOINT BONE SPINE
- Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer
- (2016) Charlene Porter et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Effectiveness of Tumor Necrosis Factor Inhibitors in Combination with Various csDMARD in the Treatment of Rheumatoid Arthritis: Data from the DREAM Registry
- (2016) S. H. M. Manders et al. JOURNAL OF RHEUMATOLOGY
- Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care
- (2016) I N Bruce et al. LUPUS
- Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data
- (2016) Maria Hoeltzenbein et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report
- (2016) Giacomo Emmi et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- State of the art: Reproduction and pregnancy in rheumatic diseases
- (2015) Monika Østensen et al. AUTOIMMUNITY REVIEWS
- Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study
- (2015) Corinna Weber-Schoendorfer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Monoclonal Antibodies, Systemic Lupus Erythematosus, and Pregnancy: Insights from an Open-label Study
- (2015) V. K. SANDHU et al. JOURNAL OF RHEUMATOLOGY
- Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review
- (2015) T. M. Kuijper et al. JOURNAL OF RHEUMATOLOGY
- Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol
- (2015) M. E. B. Clowse et al. JOURNAL OF RHEUMATOLOGY
- Pregnancy outcomes following exposure to abatacept during pregnancy
- (2015) Monica Kumar et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare
- (2015) Huifeng Yun et al. Arthritis & Rheumatology
- OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials
- (2014) M. Powell et al. ANNALS OF THE RHEUMATIC DISEASES
- Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester
- (2014) Claire Sheeran et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Rituximab impairs immunoglobulin (Ig)M and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients
- (2014) J. Westra et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Belimumab for the treatment of systemic lupus erythematosus
- (2014) Natasha Jordan et al. Expert Review of Clinical Immunology
- Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children
- (2014) Martin Bortlik et al. INFLAMMATORY BOWEL DISEASES
- Anti-TNF- Therapy May Cause Neonatal Neutropenia
- (2014) T. Guiddir et al. PEDIATRICS
- Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report
- (2014) Abhijeet Danve et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Risk of Hospitalized Bacterial Infections Associated With Biologic Treatment Among US Veterans With Rheumatoid Arthritis
- (2014) J. R. Curtis et al. ARTHRITIS CARE & RESEARCH
- Brief Report: Anakinra Use During Pregnancy in Patients With Cryopyrin-Associated Periodic Syndromes
- (2014) Zenas Chang et al. Arthritis & Rheumatology
- Fetal outcomes after rituximab exposure in women with autoimmune vasculitis
- (2013) William F Pendergraft et al. ANNALS OF THE RHEUMATIC DISEASES
- Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases
- (2013) Mario Ojeda-Uribe et al. CLINICAL RHEUMATOLOGY
- B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases
- (2013) Shirish R. Sangle et al. JOURNAL OF AUTOIMMUNITY
- From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti–tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis
- (2013) Kiran Motaparthi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases
- (2013) M. Jani et al. RHEUMATOLOGY
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- Methotrexate polyglutamation in relation to infliximab pharmacokinetics in rheumatoid arthritis
- (2012) Thierry Dervieux et al. ANNALS OF THE RHEUMATIC DISEASES
- The Effects of Interleukin-6 Signal Blockade on Fertility, Embryo-fetal Development, and Immunization In vivo
- (2012) Takayuki Sakurai et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
- (2012) Uma Mahadevan et al. Clinical Gastroenterology and Hepatology
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Abatacept therapy and safety management
- (2012) Thao Pham et al. JOINT BONE SPINE
- Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31
- (2011) Casper Steenholdt et al. Journal of Crohns & Colitis
- The Distribution of Congenital Anomalies Within the VACTERL Association Among Tumor Necrosis Factor Antagonist-exposed Pregnancies Is Similar to the General Population
- (2011) H. J. M. J. CRIJNS et al. JOURNAL OF RHEUMATOLOGY
- Development in the cynomolgus macaque following administration of ustekinumab, a human anti-il-12/23p40 monoclonal antibody, during pregnancy and lactation
- (2010) Pauline L. Martin et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Pregnancy outcomes after maternal exposure to rituximab
- (2010) E. F. Chakravarty et al. BLOOD
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
- (2010) Kuldeep Cheent et al. Journal of Crohns & Colitis
- Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
- (2010) Takuo Suzuki et al. JOURNAL OF IMMUNOLOGY
- Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys
- (2010) Anu Vaidyanathan et al. TOXICOLOGICAL SCIENCES
- Neutropenia in patients receiving anti-tumor necrosis factor therapy
- (2010) Richard Hastings et al. ARTHRITIS CARE & RESEARCH
- Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases
- (2009) Michael Elliott et al. Annals of the New York Academy of Sciences
- Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum
- (2009) A Murashima et al. ANNALS OF THE RHEUMATIC DISEASES
- A patient's wish: anakinra in pregnancy
- (2009) C T Berger et al. ANNALS OF THE RHEUMATIC DISEASES
- A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database
- (2009) J. D. CARTER et al. JOURNAL OF RHEUMATOLOGY
- Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator
- (2009) Diana J. Auyeung-Kim et al. REPRODUCTIVE TOXICOLOGY
- Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
- (2008) D. T. Klink et al. Clinical & Developmental Immunology
- 499 The Effect of Maternal Peripartum Infliximab Use On Neonatal Immune Response
- (2008) Uma Mahadevan et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More